AUROBINDO PHARMA
Back to Balance Sheet
|
AUROBINDO PHARMA Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | ₹7,942 Cr | ₹6,315 Cr | ₹4,862 Cr | ₹2,373 Cr | ₹4,972 Cr |
What is the latest Total Debt ratio of AUROBINDO PHARMA ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹7,942 Cr |
| Mar2024 | ₹6,315 Cr |
| Mar2023 | ₹4,862 Cr |
| Mar2022 | ₹2,373 Cr |
| Mar2021 | ₹4,972 Cr |
How is Total Debt of AUROBINDO PHARMA Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹7,942 Cr | 25.75 | |
| Mar2024 | ₹6,315 Cr | 29.90 | |
| Mar2023 | ₹4,862 Cr | 104.89 | |
| Mar2022 | ₹2,373 Cr | -52.28 | |
| Mar2021 | ₹4,972 Cr | - | |
Compare Total Debt of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹77,798.2 Cr | 0.3% | 8.8% | 15.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,050.0 Cr | 1.3% | -4.5% | -0% | Stock Analytics | |
| DIVIS LABORATORIES | ₹158,157.0 Cr | 1.7% | -5.9% | 3.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹138,531.0 Cr | 2.6% | -5% | 25.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,190.0 Cr | -0.4% | -7% | 3.6% | Stock Analytics | |
| CIPLA | ₹98,892.8 Cr | 2.6% | -7.4% | -16.3% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | 0.3% |
8.8% |
15.2% |
| SENSEX | 4.8% |
-4.2% |
0.8% |
You may also like the below Video Courses